Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib

NCT05095649 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Chronic Graft vs Host Disease

Interventions

BIOLOGICAL: Regulatory T-cell enriched infusion

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla